Yilin Ning, Salinelat Teixayavong, Yuqing Shang, Julian Savulescu, Vaishaanth Nagaraj, Di Miao, Mayli Mertens, Daniel Shu Wei Ting, Jasmine Chiat Ling Ong, Mingxuan Liu, Jiuwen Cao, Michael Dunn, Roger Vaughan, Marcus Eng Hock Ong, Joseph Jao-Yiu Sung, Eric J Topol 12, Nan Liu
Lancet Digit Health . 2024 Sep 17:S2589-7500(24)00143-2. doi: 10.1016/S2589-7500(24)00143-2. Online ahead of print.
The widespread use of Chat Generative Pre-trained Transformer (known as ChatGPT) and other emerging technology that is powered by generative artificial intelligence (GenAI) has drawn attention to the potential ethical issues they can cause, especially in high-stakes applications such as health care, but ethical discussions have not yet been translated into operationalisable solutions. Furthermore, ongoing ethical discussions often neglect other types of GenAI that have been used to synthesise data (eg, images) for research and practical purposes, which resolve some ethical issues and expose others. We did a scoping review of the ethical discussions on GenAI in health care to comprehensively analyse gaps in the research. To reduce the gaps, we have developed a checklist for comprehensive assessment and evaluation of ethical discussions in GenAI research. The checklist can be integrated into peer review and publication systems to enhance GenAI research and might be useful for ethics-related disclosures for GenAI-powered products and health-care applications of such products and beyond.